Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 3, 2007, Pages

  Johnston, Adam P W ^a   Campbell, Jonathan E ^a   Found, Jeremy G ^a   Riddell, Michael C ^a   Hawke, Thomas J ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Cell cycle; Diabetes; Diabetic model; Hypertrophy; Proliferation; Satellite cell; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPOINSULINEMIA; IN VIVO STUDY; MALE; MUSCLE GROWTH; MYOBLAST; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE; MALE; MUSCLE, SKELETAL; MYOBLASTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 33947309880     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00338.2006     Document Type: Article

References (37)

1. Aragno M, Mastrocola R, Catalano MG, Brignardello E, Danni O, Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53: 1082-1088, 2004.
2. Bedoya FJ, Solano F, Lucas M. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia 52: 344-547, 1996.
3. Bennett RA, Pegg AE. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res 41: 2786-2790, 1981.
4. Bhuyan BK. The action of streptozotocin on mammalian cells. Cancer Res 30: 2017-1023, 1970.
5. Bhuyan BK, Kuentzel SL, Gray LG, Fraser TJ, Wallach D, Neil GL. Tissue distribution of streptozotocin (NSC-85998). Cancer Chemother Rep 58: 157-165, 1974.
6. Blasiak J, Sikora A, Wozniak K, Drzewoski J. Genotoxicity of STZ in normal and cancer cells and its modulation by free radical scavengers. Cell Biol Toxicol 20: 83-96, 2004.
7. Bloomgarden ZT. Diabetic nephropathy. Diabetes Care 28: 745-745, 2005.
8. Bloomgarden ZT. Diabetic retinopathy and neuropathy. Diabetes Care 28: 963-970, 2005.
9. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 512: 121-134, 2002.
10. Boscoboinik D, Szewczyk A, Hensey C, Angelo A. Inhibition of cell proliferation by α-tocopherol. J Biol Chem 266: 6188-6194, 1991.
11. Brambilla G, Carlo P, Finollo R, Sciaba L. Dose-response curves for liver DNA fragmentation induced in rats by sixteen N-nitroso compounds as measured by viscometric and alkaline elution analyses. Cancer Res 47: 3485-3491, 1987.
12. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nat Med 5: 314-319, 1999.
13. Chan O, Chan S, Inouye K, Vranic M, Matthews SG. Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocininduced diabetes: effects of insulin treatment. Endocrinology 142: 4872-4879, 2001.
14. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301, 2005.
15. Dahlquist G. The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 425: 5-10, 1998.
16. Gonzalez C, Ménissier de Murcia J, Janiak P, Bidouard JP, Beauvais C, Karray S, Garchon HJ, Levi-Strauss M. Unexpected sensitivity of nonobese diabetic mice with a disrupted poly(ADP-ribose) polymerase-1 gene to streptozotocin-induced and spontaneous diabetes. Diabetes 51: 1470-1476, 2002.
17. Goodman MN. Myofibrillar protein breakdown in skeletal muscle is diminished in rats with chronic streptozocin-induced diabetes. Diabetes 36: 100-105, 1987.
18. Grzelkowska K, Dardevet D, Balage M, Grizard J. Involvement of the rapamycin-sensitive pathway in the insulin regulation of muscle protein synthesis in streptozotocin-diabetic rats. J Endocrinol 160: 137-145, 1999.
19. Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 51: 2395-2404, 2002.
20. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551, 2001.
21. Hawke TJ, Meeson AP, Jiang N, Graham S, Hutcheson K, DiMaio JM, Garry DJ. p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. Am J Physiol Cell Physiol 285: C1019-C1027, 2003.
22. Iwase M, Nunoi K, Sadoshima S, Kikuchi M, Fujishima M. Liver, kidney and islet cell tumors in spontaneously hypertensive and normotensive rats treated neonatally with streptozotocin. Tohoku J Exp Med 159: 83-90, 1989.
23. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126: 201-205, 1967.
24. Kelly F, Legator M. The effects of N-methyl- N′-nitro-N-nitrosoguanidine and streptozotocin on mammalian cell cultures. Mutat Res 12: 183-190, 1971.
25. Kornbrust DJ, Mavis RD. Relative susceptibility of microsomes from lung, heart, liver, kidney, brain and testes to lipid peroxidation: correlation with vitamin E content. Lipids 15: 315-322, 1980.
26. Lecker SH, Salomon V, Price SR, Kwon YT, Mitch WE, Goldberg AL. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 104: 1411-1420, 1999.
27. Pepato MT, Migliorini RH, Goldberg AL, Kettelhut IC. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 271: E340-E347, 1996.
28. Petzold GL, Swenberg JA. Detection of DNA damage induced in vivo following exposure of rats to carcinogens. Cancer Res 38: 1589-1594, 1978.
29. Portha B, Levacher C, Picon L, Rosselin G. Diabetogenic effect of STZ in the rat during the perinatal period. Diabetes 23: 889-895, 1974.
30. Raketien N, Raketien ML, Nadkarmi M. Studies on the diabetogenic action of STZ (NSC-37917). Cancer Chemother Rep 29: 91-98, 1963.
31. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 22: 359-370, 2005.
32. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP. STZ at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic β-cell line, INS-1. Biochem Mol Biol Int 39: 1229-1236, 1996.
33. Smith OL, Wong CY, Gelfand RA:. Skeletal muscle proteolysis in rats with acute streptozotocin-induced diabetes. Diabetes 38: 1117-1122, 1989.
34. 2 as mediator for DNA fragmentation. Diabetes 40: 1141-1145, 1991.
35. Tokuda K, Bodell WJ. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents. Cancer Res 48: 3100-3105, 1988.
36. Tyson CK, Mirsalis JC. Measurement of unscheduled DNA synthesis in rat kidney cells following in vivo treatment with genotoxic agents. Environ Mutagen 7: 889-899, 1985.
37. Yamamoto H, Uchigata Y, Okamoto H. STZ and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294: 284-286, 1981.